BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24134832)

  • 1. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system.
    Gharani N; Keller MA; Stack CB; Hodges LM; Schmidlen TJ; Lynch DE; Gordon ES; Christman MF
    Genome Med; 2013; 5(10):93. PubMed ID: 24134832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating pharmacogenomics discoveries into the clinic: an implementation framework.
    Huang RS; Gamazon ER
    Genome Med; 2013; 5(10):94. PubMed ID: 24134796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
    Klein ME; Parvez MM; Shin JG
    J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of Pharmacogenomics in Everyday Clinical Settings.
    Bank PCD; Swen JJ; Guchelaar HJ
    Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results.
    Schmidlen T; Sturm AC; Scheinfeldt LB
    J Pers Med; 2020 Apr; 10(2):. PubMed ID: 32340147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine.
    Xu R; Wang Q
    J Biomed Inform; 2013 Aug; 46(4):585-93. PubMed ID: 23570835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy.
    Kim WY; Kim HS; Oh M; Shin JG
    Transl Clin Pharmacol; 2020 Mar; 28(1):34-42. PubMed ID: 32274379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics in primary care: pharmacogenomics tests and beyond.
    Bartlett G; Antoun J; Zgheib NK
    Expert Rev Mol Diagn; 2012 Nov; 12(8):841-55. PubMed ID: 23249202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design Recommendations for Pharmacogenomics Clinical Decision Support Systems.
    Khelifi M; Tarczy-Hornoch P; Devine EB; Pratt W
    AMIA Jt Summits Transl Sci Proc; 2017; 2017():237-246. PubMed ID: 28815136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
    Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
    J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
    Shahabi P; Dubé MP
    Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a prototype system for integrating pharmacogenomics findings into clinical practice.
    Overby CL; Tarczy-Hornoch P; Kalet IJ; Thummel KE; Smith JW; Del Fiol G; Fenstermacher D; Devine EB
    J Pers Med; 2012 Nov; 2(4):241-56. PubMed ID: 23741623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing.
    Wang L; Liu H; Chute CG; Zhu Q
    BioData Min; 2015; 8():9. PubMed ID: 25729430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice.
    Adesta F; Mahendra C; Junusmin KI; Rajah AMS; Goh S; Sani L; Chan A; Irwanto A
    Front Pharmacol; 2021; 12():684907. PubMed ID: 34262455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.